Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution
Hyperthermic intraperitoneal chemoperfusion (HIPEC) is an established form of locoregional chemotherapy of peritoneum tumors. However, its efficacy and safety status remain a controversy, partially, due to scarce data on pharmacokinetics and toxicity profile of drugs under HIPEC. In the current stud...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/20/4733 |
id |
doaj-cad4b49636d14a17a43a452d8e153029 |
---|---|
record_format |
Article |
spelling |
doaj-cad4b49636d14a17a43a452d8e1530292020-11-25T03:55:00ZengMDPI AGMolecules1420-30492020-10-01254733473310.3390/molecules25204733Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue DistributionGalina Kireeva0Stepan Kruglov1Mikhail Maydin2Ekaterina Gubareva3Elena Fedoros4Ekaterina Zubakina5Natalya Ivanenko6Marina Bezruchko7Nikolay Solovyev8N.N. Petrov National Medical Research Center of Oncology, 197758 Saint Petersburg, RussiaN.N. Petrov National Medical Research Center of Oncology, 197758 Saint Petersburg, RussiaN.N. Petrov National Medical Research Center of Oncology, 197758 Saint Petersburg, RussiaN.N. Petrov National Medical Research Center of Oncology, 197758 Saint Petersburg, RussiaN.N. Petrov National Medical Research Center of Oncology, 197758 Saint Petersburg, RussiaInstitute of Toxicology, Federal Medical Biological Agency, 192019 Saint Petersburg, RussiaInstitute of Toxicology, Federal Medical Biological Agency, 192019 Saint Petersburg, RussiaInstitute of Toxicology, Federal Medical Biological Agency, 192019 Saint Petersburg, RussiaInstitute of Technology Sligo, Ash Lane, Sligo F91 YW50, IrelandHyperthermic intraperitoneal chemoperfusion (HIPEC) is an established form of locoregional chemotherapy of peritoneum tumors. However, its efficacy and safety status remain a controversy, partially, due to scarce data on pharmacokinetics and toxicity profile of drugs under HIPEC. In the current study, 24 female Wistar rats were randomly assigned to receive cisplatin as HIPEC (<i>n </i>= 12, 20 mg/kg) or intravenously (i.v., <i>n</i> = 9, 4 mg/kg). The subgroups of three animals were used for the initial, intermediate, and late phases of the pharmacokinetic assessment. The animals were sacrificed on days 1 and 5. Blood, liver, kidney, and ovaries were evaluated for platinum content. Histological and immunohistochemical evaluation was undertaken in the liver and kidney. A trend for higher blood plasma platinum levels was observed for HIPEC compared to i.v. Significantly lower (<i>p </i>< 0.001) relative platinum binding to the proteins was observed in HIPEC animals compared to the i.v. administration. A five-fold higher concentration of cisplatin in HIPEC resulted in a ca. 2.5-fold increase in total blood platinum and ca. two-fold increase in blood ultrafitrable platinum (“free” Pt). Immunohistochemistry revealed higher kidney and liver damage after i.v. administration of cisplatin compared to HIPEC, although a five-fold higher dose of cisplatin was applied in HIPEC. Together with relatively lower absorption to the systemic circulation in HIPEC, higher protein binding is probably the primary reason for lower observed toxicity in HIPEC animals.https://www.mdpi.com/1420-3049/25/20/4733<i>cis</i>-diamminedichloridoplatinum (II)hyperthermic intraperitoneal chemoperfusionWistar ratsplatinum protein bindingintravenous injectioninductively coupled plasma mass spectrometry |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Galina Kireeva Stepan Kruglov Mikhail Maydin Ekaterina Gubareva Elena Fedoros Ekaterina Zubakina Natalya Ivanenko Marina Bezruchko Nikolay Solovyev |
spellingShingle |
Galina Kireeva Stepan Kruglov Mikhail Maydin Ekaterina Gubareva Elena Fedoros Ekaterina Zubakina Natalya Ivanenko Marina Bezruchko Nikolay Solovyev Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution Molecules <i>cis</i>-diamminedichloridoplatinum (II) hyperthermic intraperitoneal chemoperfusion Wistar rats platinum protein binding intravenous injection inductively coupled plasma mass spectrometry |
author_facet |
Galina Kireeva Stepan Kruglov Mikhail Maydin Ekaterina Gubareva Elena Fedoros Ekaterina Zubakina Natalya Ivanenko Marina Bezruchko Nikolay Solovyev |
author_sort |
Galina Kireeva |
title |
Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution |
title_short |
Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution |
title_full |
Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution |
title_fullStr |
Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution |
title_full_unstemmed |
Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution |
title_sort |
modeling of chemoperfusion vs. intravenous administration of cisplatin in wistar rats: adsorption and tissue distribution |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2020-10-01 |
description |
Hyperthermic intraperitoneal chemoperfusion (HIPEC) is an established form of locoregional chemotherapy of peritoneum tumors. However, its efficacy and safety status remain a controversy, partially, due to scarce data on pharmacokinetics and toxicity profile of drugs under HIPEC. In the current study, 24 female Wistar rats were randomly assigned to receive cisplatin as HIPEC (<i>n </i>= 12, 20 mg/kg) or intravenously (i.v., <i>n</i> = 9, 4 mg/kg). The subgroups of three animals were used for the initial, intermediate, and late phases of the pharmacokinetic assessment. The animals were sacrificed on days 1 and 5. Blood, liver, kidney, and ovaries were evaluated for platinum content. Histological and immunohistochemical evaluation was undertaken in the liver and kidney. A trend for higher blood plasma platinum levels was observed for HIPEC compared to i.v. Significantly lower (<i>p </i>< 0.001) relative platinum binding to the proteins was observed in HIPEC animals compared to the i.v. administration. A five-fold higher concentration of cisplatin in HIPEC resulted in a ca. 2.5-fold increase in total blood platinum and ca. two-fold increase in blood ultrafitrable platinum (“free” Pt). Immunohistochemistry revealed higher kidney and liver damage after i.v. administration of cisplatin compared to HIPEC, although a five-fold higher dose of cisplatin was applied in HIPEC. Together with relatively lower absorption to the systemic circulation in HIPEC, higher protein binding is probably the primary reason for lower observed toxicity in HIPEC animals. |
topic |
<i>cis</i>-diamminedichloridoplatinum (II) hyperthermic intraperitoneal chemoperfusion Wistar rats platinum protein binding intravenous injection inductively coupled plasma mass spectrometry |
url |
https://www.mdpi.com/1420-3049/25/20/4733 |
work_keys_str_mv |
AT galinakireeva modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution AT stepankruglov modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution AT mikhailmaydin modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution AT ekaterinagubareva modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution AT elenafedoros modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution AT ekaterinazubakina modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution AT natalyaivanenko modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution AT marinabezruchko modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution AT nikolaysolovyev modelingofchemoperfusionvsintravenousadministrationofcisplatininwistarratsadsorptionandtissuedistribution |
_version_ |
1724471257496289280 |